EMEA-000745-PIP01-09-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Psychiatry
PIP number: P/0265/2013
Route(s) of administration: Oral use
Pharmaceutical form(s):
Prolonged-release tablet
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Intuniv
guanfacine
Attention Deficit Disorder with Hyperactivity
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
Zynquista
sotagliflozin
Diabetes Mellitus, Type 1
Date of authorisation:
Revision: 3
Last updated:
MedicineHumanWithdrawn
EMEA-001517-PIP02-14-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/0226/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Granules
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman